Rapidly disintegrating gelatinous coated tablets

An elongated dosage form comprising:

• a) an elongated core having an exterior surface and first and second ends, wherein the elongated core comprises one or more active ingredients, cellulose or a derivative of cellulose, pregelatinized starch, and magnesium stearate;
• b) a first gelatinous coating over at least part of the elongated core;
• and
• c) a second gelatinous coating over at least part of the elongated core;
• wherein the first and second gelatinous coatings are provided on the first and second ends of the elongated core;
• wherein the first and second gelatinous coatings do not touch or overlap one another;
• wherein the first and second gelatinous coatings form a gap through which the elongated core is exposed, wherein the gap has a width of greater than 7% to about 25% of a length of the elongated core;
• wherein the first and second gelatinous coatings each comprise gelatin;
• wherein the dosage form does not contain a subcoating on the core;
• wherein the dosage form allows for dissolution of the one or more active ingredients following an immediate release profile for dosage forms containing that particular active ingredient;
• and
• wherein the gap does not effect the swallowablity of the dosage form;
• wherein said dosage form is substantially free of visible bubble defects.